Healthcare -
Biotechnology - NASDAQ - US
$ 38.165
6.81 %
$ 233 M
Market Cap
-8.94
P/E
MNPR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities MNPR - Monopar Therapeutics Inc.
59.3 M
LAST VALUE
4146.97%
2 YEAR CAGR
44.70%
5 YEAR CAGR
0.00%
10 YEAR CAGR